News

Carvana Co. CVNA reported an adjusted EBITDA margin of 9.1% in the fourth quarter of 2025, down from 10.1% in the same period the previous year. The decline was primarily due to increased retail

The market expects Star Equity Holdings (STRR) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 6th:

Alto Ingredients ALTO: This company which, is a producer of specialty alcohols and

Shares of uniQure N.V. QURE plunged 31.8% in a week, primarily after the company announced a disappointing regulatory update for its investigational gene therapy, AMT-130, for the treatment of

Cheniere Energy Partners, L.P. CQP recorded fourth-quarter 2025 earnings per unit of $1.08, which beat the Zacks Consensus Estimate of $1.04. The bottom line also improved from $1.05 reported in the

Serve Robotics Inc. SERV is scheduled to report fourth-quarter 2025 results on March 11, before the opening bell. In the last reported quarter, the company registered an earnings miss of 46%.

SERV’s

Shares of Accel Entertainment (ACEL) have gained 9.1% over the past four weeks to close the last trading session at $12.19, but there could still be a solid upside left in the stock if short-term

Shares of Cognex Corporation (CGNX) have gained 29.8% over the past four weeks to close the last trading session at $51.25, but there could still be a solid upside left in the stock if short-term

Shares of Keurig Dr Pepper, Inc (KDP) have gained 0.1% over the past four weeks to close the last trading session at $28.05, but there could still be a solid upside left in the stock if short-term

Rubrik, Inc. (RBRK) closed the last trading session at $55.88, gaining 15.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Equinox Gold (EQX) closed the last trading session at $16.42, gaining 19.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Shares of Catalyst Pharmaceutical (CPRX) have gained 1.7% over the past four weeks to close the last trading session at $24.32, but there could still be a solid upside left in the stock if

Onto Innovation (ONTO) closed the last trading session at $196.89, gaining 4.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Nvidia (NVDA) closed the last trading session at $183.34, gaining 6.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Shares of Ezcorp (EZPW) have gained 9.6% over the past four weeks to close the last trading session at $25.15, but there could still be a solid upside left in the stock if short-term price targets

A downtrend has been apparent in Gold Fields (GFI) lately. While the stock has lost 14.4% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last

Intuit (INTU) closed the last trading session at $466.79, gaining 7.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

The price trend for Eldorado Gold Corporation (EGO) has been bearish lately and the stock has lost 11.1% over the past week. However, the formation of a hammer chart pattern in its last trading

After reaching an important support level, Iron Mountain Incorporated (IRM) could be a good stock pick from a technical perspective. IRM recently experienced a "golden cross" event, which saw its

Shares of OR Royalties (OR) have been struggling lately and have lost 8.5% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock

Fluor Corporation FLR entered 2026 with strong project visibility supported by a large backlog and diversified end markets. The company operates across complex engineering, procurement and

Hologic HOLX posted Diagnostics revenues of $464.4 million in the first quarter of fiscal 2026, down 1.3% from last year. The segment remains anchored by the molecular diagnostic assays, which run

Carvana Co. CVNA remains strongly committed to vertical integration, which it believes will improve both operating economics and the overall customer experience. It expects this strategy to

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates